4 Mars 2018
Doctor Michel Gaillaud has realised at the Oxford Clinic in Cannes in France a first European injection of Collagen and PRP (Platelet rich plasma) at the end of 2017.
this treatmend was made in 2 professional international football players for myo-tendinous injury.
the first was made in a Brazilian international player for a significant proximal myotendinous lesion of the adductors.
The second, a player in the first English league had a hight recurrent injury of the rectus femoralis. He had had a PRP isolated in Spain before but with recidive.
Recovery times have been shortened significantly. Thyey resumed at about 1 month instead of 3 months and do not have a new lesion yet.
PRP-Collagen is a next generation to treat tendinopathies and myotendinous injury.
Conservative treatment of all kinds of tendinopathies It is an innovative and advanced scaffold with growth factors.
The device is a recombinant human collagen (Type 1) which is biotechnologically extracted from tobacco plants. It is combined with autologous Platelet Rich Plasma (PRP) and Human Collagen.. It is injected and forms a clot in the vicinity of injured tendon injury site.
It is an advanced soft tissue repair device and a biodegradable scaffold made of lyophilized Type I rhCollagen and calcium chloride.
It contains collagen that forms a 3 ml suspension following mixing with PRP. The device is supplied in a single use kit and sterile.
it allows a single injection with less pain and accelerated healing. The growth factors are release over several weeks.
Mode of action :
Multiple functions in tissue healing
0-24h : Hemostasis & early inflammation (platelet activation)
48h : Late inflammation (Angiogenesis - Growth factor binding and release)
72h : Cell proliferation (Granulation tissue formation - Epithelial growth)
Weeks / months : Remodeling (Support mesenchymal stem cell growth, differentiation and tissue remodeling
The interaction of PRP with the rhCollagen matrix creates a growth factor depot, enabling a prolonged release of growth factors to the injury site for up to four weeks, and can promote hemostasis, tissue renewal and regeneration.
THE REGENERATIV ADVENTURE CONTINUES ,